SCHEMBL28048293

SCHEMBL28048293

COc1c(Br)ccnc1NN

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTK2 Q05397 1/20 0.36
ALOX5AP P20292 1/20 0.36
FEN1 P39748 1/20 0.36
EGFR P00533 2/20 0.35
GAK O14976 4/20 0.35
RIPK2 O43353 3/20 0.35
COQ8A Q8NI60 3/20 0.35
NLK Q9UBE8 3/20 0.35
EPHB6 O15197 2/20 0.35
ABL1 P00519 2/20 0.35
ACVR1 Q04771 2/20 0.35
STK16 O75716 1/20 0.35
AAK1 Q2M2I8 1/20 0.35
NQO2 P16083 1/20 0.34
TNF P01375 2/20 0.34
MAOA P21397 1/20 0.33
NOS3 P29474 1/20 0.32
NOS1 P29475 1/20 0.32
NOS2 P35228 1/20 0.32
ALDH1A1 P00352 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25385708 0.78 MAOA (0.33) GAKRIPK2COQ8ANLKMAOA
SCHEMBL21713526 0.75 NOS3 (0.34) EGFRMAOANOS3NOS1NOS2
SCHEMBL3711280 0.75 ALOX5AP (0.41) ALOX5APFEN1GAKRIPK2COQ8A
SCHEMBL30610404 0.74 NQO2 (0.39) ALOX5APFEN1EGFRGAKRIPK2
Methylamine SCHEMBL26629007 0.73 MAOA (0.38) ALOX5APFEN1EGFRGAKRIPK2
SCHEMBL28300760 0.73 PSMD14 (0.38) ALDH1A1GAARAB9ACA2TSHR
SCHEMBL1899766 0.72 NQO2 (0.38) ALOX5APFEN1EGFRGAKRIPK2
SCHEMBL28190331 0.72 MAOA (0.48) ALOX5APFEN1EGFRGAKRIPK2
SCHEMBL30527538 0.71 ALOX5AP (0.41) ALOX5APFEN1EGFRGAKRIPK2
SCHEMBL25283372 0.71 NQO2 (0.37) ALOX5APFEN1EGFRGAKRIPK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105263934-A Pyrazolo-pyrrolidin-4-one derivatives as bet inhibitors and their use in the treatment of disease NOVARTIS AG 2016-01-20 CN disclosed